PO-0884: Frameless radiosurgery: less invasive, more accurate  by Gevaert, T. et al.
2nd ESTRO Forum 2013   S339 
  
Conclusions: Applying the described hypofractionated TMI (4 Gy dose 
per fraction) a dose reduction to the organs at risk ranged from 
18.67%-66.48% of the prescribed dose and the effective time for one 
radiation session was 1 hour and 15 minutes (including patient 
positioning and imaging). The tomotherapy direct field angles 
arrangement instead of using the helical intensity-modulated radiation 
has allowed minimizing the delivery error associated with the setup of 
the leg positioning, especially in horizontal direction. An additional 
benefit was the shorter irradiation time. A disadvantage of the direct 
technique was poor conformality, as a result of which the non-skeletal 
structures in legs (mostly muscles and vessels) received a higher dose 
in order to ensure hitting the target. In conclusion, the applied 4 Gy 
fractionation is feasible using TomoHD system and time-efficient in a 
busy radiotherapy department, requiring only a single patient setup a 
day on three consecutive days. Through hypofractionation, the 
biological equivalent dose is also effectively increased. Further 
observation of patients treated with this scheme is necessary to 
evaluate the treatment response. 
   
PO-0882   
Current status of IMRT verification in the UK: Survey Results 
J. Cashmore1, S. Zaman2, C. Clark3 
1University Hospital Birmingham, Radiotherapy Physics, Birmingham, 
United Kingdom  
2University of Surrey, Dept of Physics, Guildford, United Kingdom  
3Royal Surrey County Hospital, Radiotherapy Physics, Guildford, 
United Kingdom  
 
Purpose/Objective: Data from the National Radiotherapy 
Implementation Group (NRIG) suggests that the provision of IMRT has 
improved from around 2% of patients in 2008 to around an estimated 
15% in 2012 (Cooper and Williams 2012). The objective of this survey 
was to determine how each centre currently carries out the quality 
assurance (QA) processes for these IMRT treatments. For the purposes 
of this survey IMRT is defined as inverse planned treatments and 
includes linac based, Tomotherapy and Cyberknife delivery. The aim 
was to collect information on equipment, approach and tolerances as 
well as how QA approaches may change in the future. 
Materials and Methods: The survey was web based, however a word 
version was also available. Questions were divided into the following 
categories: Background and equipment, machine tolerance and QA, 
machine based verification, software based verification, future plans. 
Results: 57 responses were received from 53 centres (4 centres 
answered separately for different systems). All centres use 6MV with 
27% also using 8, 10 or 15MV. 41% use dynamic delivery, 48% use step 
and shoot and 35% use VMAT with 11% using Tomotherapy. 82% are 
limiting the numbers they treat with 45% receiving extra funding for 
IMRT. 42% have developed their own tests for commissioning and QA. 
100% perform machine based measurements to check IMRT plans with 
66% measuring both point doses and dose distributions and the main 
burden falling on physics staff (94%). 74% perform machine based 
measurements for every patient, and 49% have changed their plan 
based on the results of the QA measurements. 63% perform software 
based calculations to check IMRT plans, with 88% being point doses, 
3% being dose distributions only and 9% being both. However 97% have 
never changed a plan based on the results of the calculated IMRT 
check. 73% of these calculations are performed by physicists with the 
remaining being undertaken by dosimetrists. 87% report that they 
intend to change their QA processes in the near future with 41% being 
who does the QA, 51% changing to a different measurement, 56% 
reducing the number of measurements and 41% stopping doing 
measurements altogether. 
Conclusions: All centres currently include machine based 
measurements in their QA processes. This is time consuming, taking 
up to 30 minutes per patient, even when batched. The majority have 
already started looking at other techniques and the trend is towards 
reduction of measurements and sharing of workload. 
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Purpose/Objective: Proton Therapy and Carbon Ion Therapy have 
shown very good and promising results for a number of indications. 
The synchrotrons used to date to accelerate light ions up to carbon 
are however very large and expensive. We have therefore developed 
efficient, compact, cost effective treatment units that can make light 
ions treatments available with less complexity and lower costs, for the 
benefit of more patients. The systems allow for five different light 
ions species for research and clinical use. There is promising potential 
in mixing light ions but to date a lack of facilities hinder such 
research.  
Materials and Methods: A new compact superconducting isochronous 
multiple-light-ion cyclotron has been designed by Sumitomo for 
Hydrogen (Protons), Helium Ions, Lithium Ions, Boron and Carbon Ions. 
The peak energy is >300 MeV/u and the maximum Boron range is 
about 26 cm. (≈20cm Carbon). In mixed-modality radiation therapy it 
is possible to simultaneously create a uniform distribution of 
biological effect, dose and radiation quality in the tumor volume. For 
instance, with Lithium in combination with Boron or Carbon ions, the 
Lithium ions are mainly used in the distal tumor region whereas Boron 
or Carbon ions are used closer to the patient surface. By this method 
the low LET plateau dose from Lithium is elevated significantly by 
Bragg peak Boron or Carbon ion dose delivery in the shallow tumor 
region. Pencil Beam Scanning delivery is used exclusively for maximum 
dose conformity to target volumes and minimized exposure to 
surrounding tissues and OAR.  
Results: An innovative layout and arrangement of treatment rooms 
and the relatively compact new cyclotron accelerator allows a 
significant cost reduction compared to previously built carbon ion 
treatment facilities such as HIMAC at NIRS in Chiba, Japan, HIT in 
Heidelberg, Germany and CNAO in Pavia, Italy. The overall facility 
cost and cost per Light Ions treatment room is less than the current 
market prices of proton-only facilities. High dose rates from the 
cyclotron, fast switching and continous line scanning as opposed to 
synchrotrons' intermittent beam and spot scanning techniques allow 
for shorter irradiation times and higher patient throughput. 
 Conclusions: The new light ions technology provides a compact and 
very efficient system for curative treatment of several common 
malignant tumors of:head and neck, lung, liver, prostate, bone/soft-
tissue sarcoma, cervix, and pelvis (Tsujii 2010). At a facility cost equal 
or less than today's proton-only facilities, combined with enhanced 
throughput, the cost per treatment is reduced.  
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Purpose/Objective: Stereotactic radiosurgery using frame-based 
positioning is a well-established technique for the treatment of benign 
and malignant lesions. By contrast, a new trend towards frameless 
systems using image-guided positioning techniques is gaining 
mainstream acceptance. This study was designed to compare the 
overall accuracy of the frameless with the frame-based radiosurgery 
technique and to evaluate the immobilization characteristics of a 
commercially available frameless mask, more specifically, the setup 
errors and the intrafraction motion, to the invasive fixation of the 
frame-based technique. 
Materials and Methods: Multiple hidden target tests(HTT) were 
performed to measure the overall accuracy of the two positioning 
techniques for radiosurgery (i.e. frameless using stereoscopicx-ray 
imaging and 6DOF registration/positioning and frame-based using 
invasive ring and localizer box). Forty patients with 66 brain 
metastases were enrolled for frameless stereotactic radiosurgery using 
X-ray imaging and a 6DOF robotic couch. To analyze the frameless 
characteristics positioning results were collected before and after 
treatment to assess patient setup error and intrafraction motion. The 
obtained data was bench marked to literature for comparison with 
frame-based techniques. 
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Results: The results of the HTT showed an overall three dimensional 
accuracy of 0.76 mm (SD0.46 mm) for the frameless technique, 
0.87mm (SD0.44 mm) for the frame-based technique. 
The mean 3D setup error of the frameless approach before 6DOF 
correction was 1.91 mm (SD1.25mm). The rotational errors were 
larger in the longitudinal direction (0.23° SD0.82°) compared to the 
lateral (-0.09°SD0.72°) and vertical (-0.10° SD1.03°) ones (p<0.05). 
The mean 3D intrafraction shift was 0.58 (SD0.42mm) and comparable 
to frame-based techniques.The intrafractional rotational errors were 
comparable, 0.01° (SD0.35°), 0.03°(SD0.31°), -0.03° (SD0.33°), for 
the vertical, longitudinal and lateral, respectively 
Conclusions: On the basis of phantom studies, the frameless 
technique showed comparable overall accuracy to the frame-based 
approach. The immobilization characteristics of the frameless mask 
approach are comparable to the invasive head ring used during frame-
based positioning. 
With proper immobilization and x-ray verification images, frameless 
radiosurgery can be delivered with high accuracy whilst avoiding the 
minimal invasiveness offrame-based technique, and can be considered 
to be a reliable alternative for SRS treatments 
 
PO-0885   
Implementation and validation of Pinnacle for stereotactic body 
radiotherapy with a flattening filter free linac. 
J. Krayenbuehl1, K. Loewenich1, I. Norton2, M. Zamburlini1, O. 
Riesterer1, S. Klöck1 
1University Hospital Zurich, Radiation and Oncology, Zurich, 
Switzerland  
2Philips, Radiation Oncology Systems, Fitchburg, USA  
 
Purpose/Objective: In the past two years, there has been a growing 
interest in using flattening filter free (FFF) linear accelerators. By 
removing the flattening filter a higher dose rate and a relative 
reduction of the out-of-field dose can be achieved. This could be an 
asset for stereotactic body radiotherapy (SBRT) where a high dose per 
fraction is delivered and a shorter treatment time is desired. The aim 
of this study was to evaluate and compare SBRT using FFF vs. 
flattening filtered (FF) beams optimized with the SmartArc algorithm 
in Pinnacle (Philips Medical Systems). 
Materials and Methods: Eight patients with lung metastases were 
planned using SBRT with a fractionation of 54 Gy in three fractions. 
Plans were normalized to 95% of the prescribed dose covering 95% of 
the target volume. 99% of the target should receive > 90% of the 
prescribed dose. The maximal dose allowed was set to 150%. All 
patients were planned on a TrueBeam (Varian Medical Systems) linac 
with high definition multileaf collimator using a 6 MV photon beam 
with FF and with FFF. The maximal dose rate used was 600 MU/min 
with FF and 1400 MU/min with FFF. The plans were calculated on 
Pinnacle version 9.2 using three volumetric modulated arcs (VMAT). 
Evaluation criteria of the plans was based on mean lung dose, lung 
volume dose receiving 5Gy (V5), 10Gy (V10), Paddick gradient Index 
(GI), monitor units and estimated delivery time. 
Results: The target constraints were achievable with both techniques 
and for each patient. The preliminary results showed a decrease of 
mean lung dose by 0.3 Gy as well as a reduction of V5 and V10 by 2% 
with FFF beams. The GI was similar for FFF and FF beam, but the 
volume covered by 95% of the prescribed dose could be reduced with 
FFF beams. No significant differences in MU were observed between 
FF and FFF beams. Nevertheless, the estimated delivery time could be 
reduced by a factor >2 with the FFF beams. 
Conclusions: Both FF and FFF VMAT beams planned in Pinnacle were 
able to achieve the target and organ constraints for SBRT lung 
metastases. FFF beams accomplished additional dose sparing for lung 
and reduced dose to the normal tissue. Furthermore, the irradiation 
time could be drastically reduced due to the high dose rate of FFF 
beams. This could potentially limit the dosimetric errors associated 
with intra-fraction organ and patient motion during treatment.  
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Purpose/Objective: To show that privacy-preserving machine learning 
across different hospitals and countries, without patient data ever 
leaving the hospital, is technically feasible and yields the same results 
as conventional centralized learning. 
Materials and Methods: A test network of 5 hospitals in the 
Netherlands,Belgium and Germany has been installed. It consists of 
one publicly hosted gateway node plus local nodes installed at the 
radiation oncology department of each hospital. Since data is stored 
in different systems and languages, the infrastructure automatically 
translates the local data into a common data model represented by 
ontologies (NCI Thesaurus plus custom extensions). The 
communication between gateway and the hospitals is encrypted 
according to industry standards and all access to the infrastructure is 
validated based on username and password. The local nodes extract, 
de-indentify and standardize the local patient data as well as manage 
access to it. Distributed machine learning algorithms are deployed 
across all centers (local algorithm) and the gateway(master algorithm) 
to learn a model to predict survival in lung cancer patients treated 
with radiotherapy. Only the local algorithms have access to the 
patient data. They generate aggregated results that are being sent to 
the master algorithm, which analyzes the results and updates the 
local algorithms with new information until the learning is complete 
and a final model is created by the master algorithm. Only trusted 
algorithms are deployed and all traffic between the gateway and the 
hospital is handled and audited by the infrastructure. 
Distributed Learning Flow: 
 
  
Results: We distributed a test dataset of 322 anonymized patients 
unequally across all centers, applied a distributed support vector 
machine and compared the results to a conventional support vector 
machine applied to the entire dataset centrally. Both approaches 
produced the exact same results in terms of model coefficients and 
area under the receiver operation characteristic curve (AUC=0.77). 
The distributed algorithm converged after 550 iterations with an 
execution time of two hours, compared to an execution time of less 
than one minute for the conventional method. 
Conclusions: Privacy-preserving learning without patient data ever 
leaving the hospital is technically feasible and enables multi-site, 
cross-country machine learning. It yields identical results compared to 
conventional centralized learning. It requires a distributed learning 
approach which comes with a minor penalty in execution time. But in 
exchange, we think that the data privacy and security improvements 
of the infrastructure make it more attractive to hospitals compared to 
centralized environments that require the hospital to give up control 
of its own patient data, making it easier to successfully grow the 
network.  
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Purpose/Objective: Proton therapy has several advantages over 
conventional radiotherapy. The use of compensators to achieve a 
homogeneous and superior dose distribution distally has a severe side 
